| 1 |
34046157 | The danger of diazoxide in the neonatal intensive care unit. | 2021 |
1 |
| 2 |
32274651 | The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD. | 2020 Aug |
1 |
| 3 |
34055813 | Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report. | 2020 Sep-Dec |
1 |
| 4 |
31218401 | Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning. | 2019 Aug |
1 |
| 5 |
29618011 | Effects of Diazoxide-Mediated Insulin Suppression on Glucose and Lipid Metabolism in Nondiabetic Obese Men. | 2018 Jun 1 |
4 |
| 6 |
28115493 | Esculentin-2CHa(1-30) and its analogues: stability and mechanisms of insulinotropic action. | 2017 Mar |
1 |
| 7 |
28400489 | Diazoxide for Lowering Insulin Levels in Breast Cancer Patients. | 2017 Apr |
1 |
| 8 |
28507564 | Management of the hormonal syndrome of neuroendocrine tumors. | 2017 Apr 1 |
1 |
| 9 |
26878387 | Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer. | 2016 Feb 15 |
3 |
| 10 |
27603903 | Diazoxide in Children With Obesity After Hypothalamic-Pituitary Lesions: A Randomized, Placebo-Controlled Trial. | 2016 Dec |
1 |
| 11 |
26116696 | Human Insulinomas Show Distinct Patterns of Insulin Secretion In Vitro. | 2015 Oct |
1 |
| 12 |
26137438 | A major role of insulin in promoting obesity-associated adipose tissue inflammation. | 2015 Jul |
2 |
| 13 |
26392140 | Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth. | 2015 Dec |
1 |
| 14 |
23303986 | A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. | 2012 |
1 |
| 15 |
21378174 | Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia. | 2011 Apr |
2 |
| 16 |
20028939 | Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control. | 2010 Mar |
2 |
| 17 |
19218500 | Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid. | 2009 Apr |
2 |
| 18 |
19623043 | Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness. | 2009 Sep |
1 |
| 19 |
18476985 | Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression. | 2008 Dec |
4 |
| 20 |
17289040 | Lack of effect of short-term diazoxide administration on luteinizing hormone secretion in women with polycystic ovary syndrome. | 2007 Jul |
1 |
| 21 |
17360975 | Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. | 2007 Jun |
1 |
| 22 |
17559844 | Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. | 2007 Oct |
1 |
| 23 |
17587399 | No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet. | 2007 Jul |
4 |
| 24 |
16475928 | Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. | 2006 |
1 |
| 25 |
16527842 | Diphenylhydantoin suppresses glucose-induced insulin release by decreasing cytoplasmic H+ concentration in pancreatic islets. | 2006 Jun |
1 |
| 26 |
17296510 | Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences. | 2006 Dec |
1 |
| 27 |
15339745 | Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide. | 2005 Jan |
3 |
| 28 |
15734853 | Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. | 2005 Mar |
1 |
| 29 |
15811140 | Diazoxide-mediated insulin suppression in obese men: a dose-response study. | 2005 May |
10 |
| 30 |
16356235 | Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. | 2005 |
1 |
| 31 |
14706058 | Nine weeks of bedtime diazoxide is well tolerated and improves beta-cell function in subjects with Type 2 diabetes. | 2004 Jan |
2 |
| 32 |
15220194 | Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. | 2004 Jul |
1 |
| 33 |
15333483 | Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes. | 2004 Sep |
2 |
| 34 |
12865318 | Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. | 2003 Aug |
5 |
| 35 |
12958175 | ATP-sensitive potassium channels induced in liver cells after transfection with insulin cDNA and the GLUT 2 transporter regulate glucose-stimulated insulin secretion. | 2003 Sep |
2 |
| 36 |
14660022 | Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans. | 2003 Dec 15 |
1 |
| 37 |
11815454 | Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon. | 2002 Feb |
1 |
| 38 |
12213059 | 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells. | 2002 Sep 12 |
1 |
| 39 |
12414839 | BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism. | 2002 Nov |
1 |
| 40 |
12522324 | Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes. | 2002 Dec |
1 |
| 41 |
11249067 | Characterization of secretory and morphologic properties of primary cultured endocrine cells from porcine pancreata. | 2001 Mar |
1 |
| 42 |
11078450 | Glucose-induced [Ca2+]i abnormalities in human pancreatic islets: important role of overstimulation. | 2000 Nov |
1 |
| 43 |
10050013 | Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets. | 1999 Mar 1 |
1 |
| 44 |
9473513 | Necessity of endogenous GTP derived from glucose-6-phosphate for insulin secretion augmented by glucose under protein kinase A activation. | 1998 Feb 4 |
1 |
| 45 |
9540027 | Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide. | 1998 Mar |
1 |
| 46 |
9626118 | Beneficial effect of diazoxide in obese hyperinsulinemic adults. | 1998 Jun |
2 |
| 47 |
9653515 | The nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester potentiates insulin secretion stimulated by glucose and L-arginine independently of its action on ATP-sensitive K+ channels. | 1998 Feb |
2 |
| 48 |
9724074 | Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide. | 1998 Aug |
3 |
| 49 |
9727845 | Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. | 1998 Aug |
1 |
| 50 |
9877233 | Evidence for nitric oxide mediated effects on islet hormone secretory phospholipase C signal transduction mechanisms. | 1998 Aug |
1 |